Journal of Practical Hepatology ›› 2024, Vol. 27 ›› Issue (4): 587-590.doi: 10.3969/j.issn.1672-5069.2024.04.024

• Hepatoma • Previous Articles     Next Articles

Contrast-enhanced MRI and IVIM-DWI in the diagnosis of patients with small hepatocellular carcinoma

Xia Lipeng, Chu Yuxuan, Zhao Rusheng   

  1. Department of Radiology, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
  • Received:2023-07-11 Online:2024-07-10 Published:2024-07-10

Abstract: Objective The aim of this study was to explore the diagnostic performance of contrast-enhanced magnetic resonance imaging (MRI) and intravoxel incoherent motion-diffusion weighted imaging (IVIM-DWI) in patients with small hepatocellular carcinoma (sHCC). Methods 73 patients with focal nodular hyperplasia (FNH ) were enrolled in our hospital between May 2020 and May 2023, and all patients underwent contrast-enhanced MRI and IVIM-DWI, recording the pseudo diffusion coefficient (D*), true diffusion coefficient (D) and perfusion fraction (f). The fine needle aspiration biopsies or postoperative histopathology were performed for golden diagnosis. The diagnostic efficacy of contrast-enhanced MRI and IVIM-DWI was evaluated by receiver operating characteristic (ROC) curves. Results Among the 73 patients with FNH, the histopathology examination showed sHCC in 49 cases (67.1%) and the dysplastic nodules (DN) in 24 cases(32.9%); the percentages of low signals on T1WI, high signals on T2WI, arterial phase enhancement and low signals during hepatobiliary phase in HCC lesions were 61.2%, 83.7%, 59.2% and 89.8%, all significantly higher than 20.8%, 33.3%, 25.0% and 29.2%(P<0.05) in DN lesions; the D* and D in HCC lesions were (50.9±11.6)×10-3mm2/s and (0.8±0.2)×10-3mm2/s, both significantly less than [(78.4±15.8)×10-3mm2/s and (1.2±0.3)×10-3mm2/s, P<0.05] in DN lesions, while there was no significant difference as respect to f between the two lesions [(45.6±8.7)% vs.(43.9±9.5)%, P>0.5]; the ROC analysis showed the AUC was 0.968, with the sensitivity of 100.0% and the specificity of 86.0%, when the T1WI and T2WI signals, arterial phase enhancement, hepatobiliary phase signal, D* and D was combined for the diagnosis of sHCC. Conclusion The contrast-enhanced MRI and IVIM-DWI are efficacious in the diagnosis of patients with sHCC, which might provide the clinicians a reliably tool for early differentiation of patients with FNH.

Key words: Hepatoma, Dysplastic nodules, Contrast-enhanced magnetic resonance imaging, Intravoxel incoherent motion-diffusion weighted imaging, Diagnosis